🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Reactive Balance Training Versus Conventional Balance Training on Dynamic Stability and Change-of-Direction Performance in Competitive Tennis Players

RecruitingNAAges 18 Years - 25 YearsAllIbadat International University, Islamabad
NCT07590674 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial aims to compare the effectiveness of reactive balance training versus conventional balance training on dynamic stability and change of direction performance. Participants will be randomly allocated into two groups. Each group will receive its respective intervention over a 6-week period. Outcome measures, including dynamic stability assessed by the Y-Balance Test and change-of-direction performance measured using the 505 Agility Test, will be evaluated at baseline and after the intervention. The study is designed to determine which training approach is more effective in improving balance and functional performance.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male and female competitive tennis players aged 18-25 years. * Minimum 2 years of regular tennis training experience. * Currently training at least 3 sessions per week (minimum 60 minutes per session). Exclusion Criteria: * Recent injury (last 3 months) * Neurological, balance or vestibular disorders * Previous surgery * Participation in any structured balance, neuromuscular, plyometric, or agility training program outside regular tennis practice during the study period. * Use of ankle/knee braces or orthotic devices that may influence balance performance.
💊

What it tests

  • Experimental group : Reactive Balance Training
  • Active comparator ( Conventional Balance Training)
📍

Where

1 site
Ibadat International University, Islamabad (Iiui)
Islamabad, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy